Marcus Peeters
5 Papers
5 Citations
Marcus Peeters is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Systematic review and meta-analysis of local resection or transanal endoscopic microsurgery versus radical resection in stage i rectal cancer: A real standard?
Geneviève Veereman,Joan Vlayen,Jo Robays,Nicolas Fairon,Sabine Stordeur,Christian Rolfo,Didier Bielen,Alain Bols,Pieter Demetter,André D'Hoore,Karin Haustermans,Alain Hendlisz,Arnaud Lemmers,Daniel Leonard,Freddy Penninckx,Eric Van Cutsem,Marcus Peeters +16 more
TL;DR: The authors strongly recommend radical resection for T2 rectal cancer, but consider 'en bloc' local resection sufficient for pT1 sm1 rectal cancers when confirmed pathologically.
36
SoMore trial: Early metabolic response assessment of a sorafenib (SOR) and capecitabine (CAP) combination in chemorefractory metastatic colorectal cancer (mCRC).
Am Lie Deleporte,Alain Hendlisz,Camilo Garcia,Thierry Delaunoit,Raphaël Maréchal,Marcus Peeters,Stéphane Holbrechts,Marc Van den Eynde,Ghislain Houbiers,Bertrand Filleul,Jean-Luc Van Laethem,Christian Rolfo,Marie Diaz,Renaud Lhommel,Gauthier Demolin,Michel Moreau,Lieveke Ameye,Marianne Paesmans,Martine Piccart-Gebhart,Patrick Flamen +19 more
TL;DR: SoMore aims to substantiate the SOR-CAP combination’s effects in mCRC refractory to all medications and the predictive value of early metabolic response (MR) on survival and to compare OS between pts with and without MR.
7
SO-32 Entrectinib in NTRK fusion-positive gastrointestinal cancers: Updated integrated analysis
Ignacio Garrido-Laguna,Sara Lonardi,Lyudmila Bazhenova,Marcus Peeters,Federico Longo,Darren Sigal,Paul Conkling,Florence Duffaud,Dirk Klingbiel,Walter Bordogna,Fortunato Ciardiello +10 more
TL;DR: For example, Entrectinib was associated with an ORR of 50.0% in patients with NTRK fusion-positive gastrointestinal cancers and had a manageable safety profile as mentioned in this paper .
4
Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group.
Francesco Sclafani,Elisa Fontana,Lucjan Wyrwicz,Anna Dorothea Wagner,Juan W. Valle,Elizabeth C Smyth,Marcus Peeters,Radka Obermannova,Cindy Neuzillet,Manfred P. Lutz,Thibaud Koessler,Irit Ben-Aharon,Dirk Arnold,Maria Alsina,Markus Moehler +14 more
TL;DR: The results of important selected studies presented at the 2022 ASCO Gastrointestinal Cancer Symposium, putting them in perspectives and highlighting potential implications for routine practice, were discussed in this article .
1
P-170 The MATTERS trial: A first-in-human study of whole-body hyperthermia in advanced solid cancer patients
Ivana Gorbaslieva,R. Dankerlui,Dirk Ysebaert,Vera Saldien,Timon Vandamme,Leila Brancato,O. Rudenko,Lien Van den Bossche,J. Van den Bossche,K. van den Cruys,J.A. Bogers,Marcus Peeters +11 more
TL;DR: In this article , a first-in-human study of WBHT in advanced (gastrointestinal) cancers was investigated, where WBHT is applied under deep anesthesia in an operating theatre.
1